Clinical Trial Update: Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the impact of oophorectomy and estrogen therapy on cardiovascular disease risk in young women has completed and posted results in 2024.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Estrogen therapy (estradiol)

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiovascular Risk Reduction | Phase 2 | Status: COMPLETED | Results posted: 2024-10-23